• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《良性前列腺增生所致下尿路症状的外科治疗管理:2020 年 AUA 指南修订版》

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2020.

机构信息

UCSD School of Medicine, La Jolla, California.

出版信息

J Urol. 2020 Oct;204(4):799-804. doi: 10.1097/JU.0000000000001298. Epub 2020 Jul 23.

DOI:10.1097/JU.0000000000001298
PMID:32698710
Abstract

PURPOSE

The AUA Guideline panel provides evidence-based recommendations for the surgical management of male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).

MATERIALS AND METHODS

The Panel amended the Guideline in 2020 to reflect additional literature published through September 2019. When sufficient evidence existed, the Panel assigned the body of evidence a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, the Panel provided additional information as Clinical Principles and Expert Opinions (See table 1[Table: see text]).

RESULTS

Amendments to these Guidelines include: 1) an amended statement (Guideline 1) to include conducting a physical examination; 2) a new statement (Guideline 6) discussing concepts of treatment failure and retreatment; 3) an amended statement (Guideline 15) with updated supporting text for prostatic urethral lift (PUL); 4) an amended statement (Guideline 16) for PUL; 5) an amended statement (Guideline 17) with updated supporting text for transurethral microwave therapy (TUMT); 6) an amended statement (Guideline 18) with updated supporting text for water vapor thermal therapy; 7) updated supporting text for water vapor thermal therapy (Guideline 19); 8) an amended statement (Guideline 21) with updated supporting text for laser enucleation; 9) an amended statement (Guideline 22) with updated supporting text for Aquablation; and 10) an amended statement (Guideline 23) with updated supporting text for Prostate Artery Embolization (PAE).

CONCLUSIONS

These evidence-based updates to the AUA Guidelines further inform the surgical management of LUTS/BPH.

摘要

目的

AUA 指南小组为良性前列腺增生(BPH)引起的男性下尿路症状(LUTS)的手术治疗提供了循证建议。

材料和方法

小组于 2020 年修订了指南,以反映截至 2019 年 9 月发表的其他文献。当有足够的证据时,小组为证据体分配了 A(高)、B(中)或 C(低)强度等级,以支持强、中或条件推荐。在缺乏足够证据的情况下,小组提供了更多的临床原则和专家意见(见表 1[表:见正文])。

结果

对这些指南的修订包括:1)修订了一项声明(指南 1),包括进行体格检查;2)新增了一项声明(指南 6),讨论了治疗失败和再治疗的概念;3)修订了一项声明(指南 15),更新了前列腺尿道抬起术(PUL)的支持文本;4)修订了一项声明(指南 16),用于 PUL;5)修订了一项声明(指南 17),更新了经尿道微波治疗(TUMT)的支持文本;6)修订了一项声明(指南 18),更新了水蒸气热疗的支持文本;7)更新了水蒸气热疗的支持文本(指南 19);8)修订了一项声明(指南 21),更新了激光前列腺切除术的支持文本;9)修订了一项声明(指南 22),更新了 Aquablation 的支持文本;10)修订了一项声明(指南 23),更新了前列腺动脉栓塞术(PAE)的支持文本。

结论

这些基于证据的 AUA 指南更新进一步为 LUTS/BPH 的手术治疗提供了信息。

相似文献

1
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2020.《良性前列腺增生所致下尿路症状的外科治疗管理:2020 年 AUA 指南修订版》
J Urol. 2020 Oct;204(4):799-804. doi: 10.1097/JU.0000000000001298. Epub 2020 Jul 23.
2
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019.《良性前列腺增生所致下尿路症状的外科治疗:2019 年 AUA 指南修订版》
J Urol. 2019 Sep;202(3):592-598. doi: 10.1097/JU.0000000000000319. Epub 2019 Aug 8.
3
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023.良性前列腺增生 (BPH) 相关下尿路症状的管理:2023 年 AUA 指南修订版。
J Urol. 2024 Jan;211(1):11-19. doi: 10.1097/JU.0000000000003698. Epub 2023 Sep 14.
4
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II-Surgical Evaluation and Treatment.良性前列腺增生所致下尿路症状的管理:AUA 指南第二部分-手术评估与治疗。
J Urol. 2021 Oct;206(4):818-826. doi: 10.1097/JU.0000000000002184. Epub 2021 Aug 13.
5
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline.良性前列腺增生所致下尿路症状的外科治疗:AUA 指南。
J Urol. 2018 Sep;200(3):612-619. doi: 10.1016/j.juro.2018.05.048. Epub 2018 Jun 11.
6
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management.良性前列腺增生所致下尿路症状的管理:AUA 指南第 I 部分-初始检查和药物治疗。
J Urol. 2021 Oct;206(4):806-817. doi: 10.1097/JU.0000000000002183. Epub 2021 Aug 13.
7
The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.新型微创治疗良性前列腺增生相关下尿路症状的作用。
BJU Int. 2020 Sep;126(3):317-326. doi: 10.1111/bju.15154. Epub 2020 Aug 3.
8
New and Emerging Technologies in Treatment of Lower Urinary Tract Symptoms From Benign Prostatic Hyperplasia.新型和新兴技术在治疗良性前列腺增生所致下尿路症状中的应用。
Sex Med Rev. 2019 Jul;7(3):491-498. doi: 10.1016/j.sxmr.2018.02.003. Epub 2018 Mar 30.
9
The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.前列腺尿道提升术治疗良性前列腺增生引起的前列腺增大相关下尿路症状:LIFT 研究。
J Urol. 2013 Dec;190(6):2161-7. doi: 10.1016/j.juro.2013.05.116. Epub 2013 Jun 11.
10
Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.经尿道前列腺电切术(TURP)候选患者中微创前列腺尿道提升术(PUL)的疗效:2 年后德国多中心评估。
World J Urol. 2019 Jul;37(7):1353-1360. doi: 10.1007/s00345-018-2494-1. Epub 2018 Oct 3.

引用本文的文献

1
One-year outcomes of glue prostate-artery-embolization for symptomatic benign prostatic hyperplasia: a single-center retrospective cohort study.胶水前列腺动脉栓塞术治疗有症状良性前列腺增生的一年期疗效:一项单中心回顾性队列研究
Eur Radiol. 2025 Aug 29. doi: 10.1007/s00330-025-11983-6.
2
Prostate Cancer and the Rise of Focal Laser Therapies: A Narrative Review of Benefits and Limitations.前列腺癌与聚焦激光治疗的兴起:益处与局限性的叙述性综述
J Lasers Med Sci. 2025 Jun 9;16:e16. doi: 10.34172/jlms.2025.16. eCollection 2025.
3
A comparative analysis of the outcomes of Rezūm therapy based on prostate size: a four-year retrospective analysis.
基于前列腺大小的Rezūm疗法疗效比较分析:一项四年回顾性分析。
World J Urol. 2025 Jul 17;43(1):443. doi: 10.1007/s00345-025-05793-0.
4
1470 nm diode laser enucleation versus bipolar transurethral resection of the prostate for the surgical management of benign prostatic hyperplasia: a randomized comparison.1470纳米二极管激光剜除术与双极经尿道前列腺切除术治疗良性前列腺增生症的手术管理:一项随机对照研究
Lasers Med Sci. 2025 May 17;40(1):226. doi: 10.1007/s10103-025-04478-9.
5
Modified early apical release vs. non-early apical release in holmium laser prostatic enucleation Impact on stress urinary incontinence.钬激光前列腺剜除术中改良早期尖部松解与非早期尖部松解对压力性尿失禁的影响
Can Urol Assoc J. 2025 Aug;19(8):242-248. doi: 10.5489/cuaj.9099.
6
Comparison of outcome for holmium laser enucleation prostate and Rezum system in benign prostate hyperplasia: a matched pair analysis.钬激光前列腺剜除术与Rezum系统治疗良性前列腺增生症的疗效比较:配对分析
World J Urol. 2025 Apr 22;43(1):242. doi: 10.1007/s00345-025-05644-y.
7
[Correlation between urination intermittences and urodynamic parameters in benign prostatic hyperplasia patients].[良性前列腺增生患者排尿间歇性与尿动力学参数的相关性]
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Apr 18;57(2):328-333. doi: 10.19723/j.issn.1671-167X.2025.02.017.
8
Comparative efficacy and safety of greenlight laser vaporization, anatomical vaporization, and enucleation for benign prostatic hyperplasia: a systematic review and meta-analysis.绿激光汽化术、解剖性汽化术和剜除术治疗良性前列腺增生的疗效与安全性比较:一项系统评价和荟萃分析
Lasers Med Sci. 2025 Mar 14;40(1):139. doi: 10.1007/s10103-025-04389-9.
9
Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990-2021.1990 - 2021年中东和北非地区良性前列腺增生的负担
BMC Public Health. 2025 Feb 7;25(1):500. doi: 10.1186/s12889-025-21735-2.
10
Water vapor thermal therapy for treatment of lower urinary tract symptoms due to large benign prostatic hyperplasia (≥ 80 g).水蒸气热疗法治疗良性前列腺增生较大(≥80克)所致下尿路症状
World J Urol. 2025 Jan 13;43(1):69. doi: 10.1007/s00345-024-05433-z.